News

Bristol Myers Squibb (BMS) has announced that its CD19-directed CAR T cell therapy Breyanzi (lisocabtagene maraleucel) has ...
Opinion
Zacks Investment Research on MSN5hOpinion

Top Research Reports for Lowe's, Bristol-Myers & Marvell Technology

Friday, August 15, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Lowe's ...
Study reveals one-third of mantle cell lymphoma patients in a study at leading cancer centers experienced disease progression ...